BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30175779)

  • 1. Investigation of Intracellular Delivery of NuBCP-9 by Conjugation with Oligoarginines Peptides in MDA-MB-231 Cells.
    Wang W; Suga T; Hagimori M; Kuroda N; Fuchigami Y; Kawakami S
    Biol Pharm Bull; 2018; 41(9):1448-1455. PubMed ID: 30175779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular delivery of peptide cargos using iron oxide based nanoparticles: studies on antitumor efficacy of a BCL-2 converting peptide, NuBCP-9.
    Kumar M; Singh G; Sharma S; Gupta D; Bansal V; Arora V; Bhat M; Srivastava SK; Sapra S; Kharbanda S; Dinda AK; Singh H
    Nanoscale; 2014 Nov; 6(23):14473-83. PubMed ID: 25340469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8.
    Watkins CL; Sayers EJ; Allender C; Barrow D; Fegan C; Brennan P; Jones AT
    Mol Ther; 2011 Dec; 19(12):2124-32. PubMed ID: 21934653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular delivery of peptide cargos using polyhydroxybutyrate based biodegradable nanoparticles: Studies on antitumor efficacy of BCL-2 converting peptide, NuBCP-9.
    Kapoor S; Gupta D; Kumar M; Sharma S; Gupta AK; Misro MM; Singh H
    Int J Pharm; 2016 Sep; 511(2):876-89. PubMed ID: 27492021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.
    Kumar M; Gupta D; Singh G; Sharma S; Bhat M; Prashant CK; Dinda AK; Kharbanda S; Kufe D; Singh H
    Cancer Res; 2014 Jun; 74(12):3271-81. PubMed ID: 24741005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement.
    Nakase I; Niwa M; Takeuchi T; Sonomura K; Kawabata N; Koike Y; Takehashi M; Tanaka S; Ueda K; Simpson JC; Jones AT; Sugiura Y; Futaki S
    Mol Ther; 2004 Dec; 10(6):1011-22. PubMed ID: 15564133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of an oligoarginine peptide displaying rapid cell penetration for improved intestinal absorption].
    Takayama K
    Yakugaku Zasshi; 2014; 134(1):55-61. PubMed ID: 24389618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel system to achieve one-pot modification of cargo molecules with oligoarginine vectors for intracellular delivery.
    Takayama K; Tadokoro A; Pujals S; Nakase I; Giralt E; Futaki S
    Bioconjug Chem; 2009 Feb; 20(2):249-57. PubMed ID: 19161253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine carrier peptide bearing Ni(II) chelator to promote cellular uptake of histidine-tagged proteins.
    Futaki S; Niwa M; Nakase I; Tadokoro A; Zhang Y; Nagaoka M; Wakako N; Sugiura Y
    Bioconjug Chem; 2004; 15(3):475-81. PubMed ID: 15149174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
    Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
    J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
    Khalil IA; Kogure K; Futaki S; Harashima H
    J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of absorption-enhancing abilities of cationic oligopeptides with short chain arginine residues through conjugation to hyaluronic acid.
    Tomono T; Yagi H; Kanemoto S; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2022 Mar; 616():121519. PubMed ID: 35093459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans.
    Kosuge M; Takeuchi T; Nakase I; Jones AT; Futaki S
    Bioconjug Chem; 2008 Mar; 19(3):656-64. PubMed ID: 18269225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity.
    Wu RP; Youngblood DS; Hassinger JN; Lovejoy CE; Nelson MH; Iversen PL; Moulton HM
    Nucleic Acids Res; 2007; 35(15):5182-91. PubMed ID: 17670797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
    Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q
    J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy.
    Choi Y; McCarthy JR; Weissleder R; Tung CH
    ChemMedChem; 2006 Apr; 1(4):458-63. PubMed ID: 16892381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
    Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
    Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
    Golan M; Feinshtein V; David A
    Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
    Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q
    Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.